Acute effects of butyrate on intestinal permeability in patients with irritable bowel syndrome assessed by a novel colonoscopy research model
Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder for which effective treatment strategies are insufficient. Butyrate, a microbiota-derived short-chain fatty acid believed to strengthen the intestinal barrier function, might be a potential new treatment option. This study aimed...
Saved in:
| Main Authors: | Mathias W. Scharf, Richard A. Forsgård, Samira B. R. Prado, John-Peter Ganda Mall, Dirk Repsilber, Robert J. Brummer, Tatiana M. Marques, Rebecca Wall |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Gut Microbes |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2025.2545414 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sodium butyrate in Irritable Bowel Syndrome
by: Aleksandra Kołodziej, et al.
Published: (2025-06-01) -
Electrogenic transport of amino acids and glucose differs between jejunum and ileum of female and castrated male finishing pigs
by: Marco Tretola, et al.
Published: (2024-12-01) -
Two mechanisms of membrane digestion: enzymatic-transport ensemble exists
by: S. T. Metelsky, et al.
Published: (2010-11-01) -
Effect of nano- and micro-polystyrene particles on small intestinal epithelial functions and enteric neuronal activity in vitro
by: Kristin Elfers, et al.
Published: (2025-02-01) -
How leaky is the gut in Parkinson’s disease?
by: Pascal Derkinderen, et al.
Published: (2025-07-01)